Demand and costs for care are rising at the same time that a labor shortage threatens to worsen. How can you plan for this need now?
Category: Medicaid
-
The House Passed Trump’s Megabill. Bond Investors Are Worried.
Republicans brought the president’s tax cuts one step closer to reality, but Wall Street remains on edge about the fiscal costs.
-
Russell Vought, Trump’s Budget Chief, Wants to Cut ‘Woke’ Spending
Russell T. Vought, leader of the Office of Management and Budget, aims to marry extreme austerity with his Christian values.
-
Senators Grill Dr. Oz on Medicaid Cuts and Medicare Changes
Dr. Mehmet Oz, the TV celebrity, dodged queries about Republican plans to cut health insurance for the poor, and emerged unscathed on his ties to major industries.
-
Dr. Oz Faces Senators at Confirmation Hearing to Oversee Medicare and Medicaid
The Senate Finance Committee holds a confirmation hearing on Friday for Dr. Mehmet Oz, the TV celebrity who is nominated to run major health programs for older Americans and the poor.
-
GOP Gambles on Budget Plan That Helps the Rich and Cuts Aid to the Poor
The House Republican budget plan would pair tax cuts that primarily benefit the rich with cuts to programs that help the poor.
-
Dr. Oz: How His Millions Collide With Medicare
The TV celebrity and Trump nominee has pledged to divest from most of his financial interests. But they touch nearly every corner of health care, from insurance to blood pressure cuffs and vitamins, leading experts and lawmakers to doubt he could make impartial decisions.
-
Oz, Trump’s Medicare Nominee, Pledges to Divest Interests in Health Care Stocks
The celebrity doctor said he would divest from his interests in many drug, medical and insurance companies, worth millions of dollars.
-
The $8 Billion Children’s Vaccine Fund Kennedy Would Oversee
If confirmed by the Senate to be the nation’s health secretary, Robert F. Kennedy Jr. would have vast powers over immunization policies for children and adults.
-
Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picks
Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes.